BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27449203)

  • 21. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
    Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
    Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Isorhynchophylline treatment improves the amyloid-β-induced cognitive impairment in rats via inhibition of neuronal apoptosis and tau protein hyperphosphorylation.
    Xian YF; Mao QQ; Wu JC; Su ZR; Chen JN; Lai XP; Ip SP; Lin ZX
    J Alzheimers Dis; 2014; 39(2):331-46. PubMed ID: 24164737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STI571 prevents apoptosis, tau phosphorylation and behavioural impairments induced by Alzheimer's beta-amyloid deposits.
    Cancino GI; Toledo EM; Leal NR; Hernandez DE; Yévenes LF; Inestrosa NC; Alvarez AR
    Brain; 2008 Sep; 131(Pt 9):2425-42. PubMed ID: 18559370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lamotrigine attenuates cerebral ischemia-induced cognitive impairment and decreases β-amyloid and phosphorylated tau in the hippocampus in rats.
    Han H; Qian Q; Yu Y; Zhao D; Sun G
    Neuroreport; 2015 Aug; 26(12):723-7. PubMed ID: 26164461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risperidone ameliorated Aβ
    Wu L; Feng X; Li T; Sun B; Khan MZ; He L
    Behav Brain Res; 2017 Mar; 322(Pt A):145-156. PubMed ID: 28093254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition.
    Pontecorvo MJ; Devous MD; Navitsky M; Lu M; Salloway S; Schaerf FW; Jennings D; Arora AK; McGeehan A; Lim NC; Xiong H; Joshi AD; Siderowf A; Mintun MA;
    Brain; 2017 Mar; 140(3):748-763. PubMed ID: 28077397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fuzhisan Ameliorates the Memory Deficits in Aged SAMP8 Mice via Decreasing Aβ Production and Tau Hyperphosphorylation of the Hippocampus.
    Zhang ZX; Zhao RP; Wang DS; Li YB
    Neurochem Res; 2016 Nov; 41(11):3074-3082. PubMed ID: 27518086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overexpression of wild-type human APP in mice causes cognitive deficits and pathological features unrelated to Abeta levels.
    Simón AM; Schiapparelli L; Salazar-Colocho P; Cuadrado-Tejedor M; Escribano L; López de Maturana R; Del Río J; Pérez-Mediavilla A; Frechilla D
    Neurobiol Dis; 2009 Mar; 33(3):369-78. PubMed ID: 19101630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential accumulation of Tau phosphorylated at residues Thr231, Ser262 and Thr205 in hippocampal interneurons and its modulation by Tau mutations (VLW) and amyloid-β peptide.
    Dávila-Bouziguet E; Targa-Fabra G; Ávila J; Soriano E; Pascual M
    Neurobiol Dis; 2019 May; 125():232-244. PubMed ID: 30553886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Abeta exacerbates the neuronal dysfunction caused by human tau expression in a Drosophila model of Alzheimer's disease.
    Folwell J; Cowan CM; Ubhi KK; Shiabh H; Newman TA; Shepherd D; Mudher A
    Exp Neurol; 2010 Jun; 223(2):401-9. PubMed ID: 19782075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice.
    Ittner A; Chua SW; Bertz J; Volkerling A; van der Hoven J; Gladbach A; Przybyla M; Bi M; van Hummel A; Stevens CH; Ippati S; Suh LS; Macmillan A; Sutherland G; Kril JJ; Silva AP; Mackay JP; Poljak A; Delerue F; Ke YD; Ittner LM
    Science; 2016 Nov; 354(6314):904-908. PubMed ID: 27856911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Up-regulation of Alzheimer's disease-associated proteins may cause enflurane anesthesia induced cognitive decline in aged rats.
    Liu H; Weng H
    Neurol Sci; 2014 Feb; 35(2):185-9. PubMed ID: 23934553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampal phosphorylated tau induced cognitive decline, dendritic spine loss and mitochondrial abnormalities in a mouse model of Alzheimer's disease.
    Kandimalla R; Manczak M; Yin X; Wang R; Reddy PH
    Hum Mol Genet; 2018 Jan; 27(1):30-40. PubMed ID: 29040533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genistein attenuates amyloid-beta-induced cognitive impairment in rats by modulation of hippocampal synaptotoxicity and hyperphosphorylation of Tau.
    Petry FDS; Hoppe JB; Klein CP; Dos Santos BG; Hözer RM; Bifi F; Matté C; Salbego CG; Trindade VMT
    J Nutr Biochem; 2021 Jan; 87():108525. PubMed ID: 33065257
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PE859, A Novel Curcumin Derivative, Inhibits Amyloid-β and Tau Aggregation, and Ameliorates Cognitive Dysfunction in Senescence-Accelerated Mouse Prone 8.
    Okuda M; Fujita Y; Hijikuro I; Wada M; Uemura T; Kobayashi Y; Waku T; Tanaka N; Nishimoto T; Izumi Y; Kume T; Akaike A; Takahashi T; Sugimoto H
    J Alzheimers Dis; 2017; 59(1):313-328. PubMed ID: 28598836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pim1 inhibition as a novel therapeutic strategy for Alzheimer's disease.
    Velazquez R; Shaw DM; Caccamo A; Oddo S
    Mol Neurodegener; 2016 Jul; 11(1):52. PubMed ID: 27412291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electroacupuncture at GV24 and bilateral GB13 improves cognitive ability via influences the levels of Aβ, p-tau (s396) and p-tau (s404) in the hippocampus of Alzheimer's disease model rats.
    Yang Y; Hu S; Lin H; He J; Tang C
    Neuroreport; 2020 Oct; 31(15):1072-1083. PubMed ID: 32881772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Traumatic Brain Injury by Weight-Drop Method Causes Transient Amyloid-
    Shishido H; Ueno M; Sato K; Matsumura M; Toyota Y; Kirino Y; Tamiya T; Kawai N; Kishimoto Y
    Behav Neurol; 2019; 2019():3248519. PubMed ID: 30944661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.